Impact Factor
4.72
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
8.51
6,469 total citations
h5-index
92
h5 depth signal
Cited share
90.3%
728 of 806
Total citations
6,469
Citation footprint
Metric signal
8.51
External metric anchor
Self-citation
0.7%
47 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United Kingdom
1,246
United States
1,216
China
744
Germany
441
France
370
Citing Fields of Research
Oncology
1,915
Breast Cancer
783
Cancer & Development
782
Immunology
679
Liver & Colon Cancer
667
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
28,090
Articles tracked across the journal lifetime
Indexed publication set
806
728 cited publications
Last 12 months
421
35.1 publications/month
Open access share
59.9%
252 OA publications in the last year
Leading citing country
United Kingdom
1,246 citing publications
Leading citing field
Oncology
1,915 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v19n3,Sept. 1965-
v1,1947-
Active Coverage
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Immunology
Breast Cancer
Cancer & Development
Liver & Colon Cancer
Lung Cancer
Issuing & Sponsoring Bodies
Contributor
British Empire Cancer Campaign
Contributor
Cancer Research UK
Broad Categories
Neoplasms
Immunology
Breast Cancer
Liver & Colon Cancer
Lung Cancer
Prostate Cancer
Cancer, Autophagy & Apoptosis
Cancer & Development
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1038/s41416-026-03630-8
Open DOI
Waiting times and determinants of delay for head and neck cancer in England—a population cohort study using real world data
Background In Head and Neck Cancer (HNC), even short delays in treatment can worsen prognosis. We used real-world data to quantify waiting times and identify patient, tumour and health service factors associated with treatment delay in E...
03
DOI 10.1038/s41416-026-03634-4
Open DOI
Preclinical efficacy of a systemically-administered, second-generation STING agonist that promotes anti-tumour immunity in combination with radiotherapy
Background As potent triggers of innate immunity, STING agonists hold promise as active immunotherapeutic agents for cancer treatment. Second-generation STING agonists, suitable for systemic delivery, are being investigated in preclinica...
04
05
DOI 10.1038/s41416-026-03631-7
Open DOI
Paediatric therapeutic development workshop on desmoplastic small round cell tumours
06
DOI 10.1038/s41416-026-03641-5
Open DOI
Using the Geriatric Core Dataset (G-CODE) to predict mortality in older patients with cancer: development and external validation
Background The Geriatric Core Dataset (G-CODE) was developed to standardise geriatric assessment (GA) in older adults with cancer. This study aimed to develop and externally validate a mortality prediction score based on the G-CODE at 6-...
07
DOI 10.1038/s41416-026-03632-6
Open DOI
Hypoxia-induced HMGB1/NLRP3/Caspase-1 signaling axis enhances proliferation of oral squamous cell carcinoma
Background The hypoxic microenvironment, a common feature of solid tumors, is critically involved in driving cancer malignancy. This research focuses on elucidating the function of high mobility group box 1 (HMGB1), induced by such hypox...
08
09
DOI 10.1038/s41416-026-03627-3
Open DOI
Trends in incidence and prevalence of patients living long-term with de novo metastatic incurable cancer: a retrospective cohort study
Background Therapeutic advances have improved the survival of incurable cancer patients, creating a growing population living long-term with incurable cancer. However, little is known about their epidemiological characteristics. We aimed...
10
DOI 10.1038/s41416-026-03637-1
Open DOI
Integrated spatial and single-cell transcriptomics uncover IFI6⁺ regulatory T-cells and SPP1⁺ macrophages immunosuppressive niches in colorectal cancer
Background: In colorectal cancer (CRC), tumor-immune interactions are critical drivers of tumorigenesis, immune evasion, and therapeutic response. Therefore, a deeper spatially resolved understanding of these interactions is urgently nee...
Bibliographical & Catalog Notes
Issues for July 1989- on cover have at head of title: BJC.
Place of publication varies.
Also issued online.
Official journal of the British Empire Cancer Campaign; Cancer Research UK, 2002-
Vols. for 1973-1996 have supplement: British journal of cancer. Supplement, no. 1-29. Suppls. for 1997- are numbered as part of individual v. of the main journal, e.g. v. 75, suppl. 1, and classed with it at NLM.
Vol. 69, no. 1 (JAN 1994)19960129 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper